Hiroaki Yoshida Selected Research

Hiroaki Yoshida Research Topics

Disease

2	Infections 12/2021 - 12/2009
2	Neoplasms (Cancer) 04/2018 - 01/2007
1	COVID-19 12/2021
1	Endometriosis 12/2019
1	Seizures (Absence Seizure) 01/2019
1	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2019
1	Dehydration (Water Stress) 09/2016
1	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 01/2016
1	Ehlers-Danlos Syndrome (Syndrome, Ehlers-Danlos) 01/2016
1	Malignant Hyperthermia 01/2016
1	Metabolic Diseases (Metabolic Disease) 01/2016
1	Muscular Atrophy (Muscle Atrophy) 01/2016
1	Neuromuscular Diseases (Neuromuscular Disease) 01/2016
1	Obesity 01/2016
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2016
1	Sensation Disorders 01/2016
1	Chronic Periodontitis 01/2016
1	Odontogenic Cysts (Keratocyst) 09/2014
1	Dermoid Cyst (Dermoid) 09/2014
1	Dentigerous Cyst 09/2014
1	Radicular Cyst 09/2014
1	Odontogenic Tumors (Dental Tissue Neoplasm) 09/2014
1	Stroke (Strokes) 01/2013
1	Lipoprotein Glomerulopathy 12/2010
1	Proteinuria 12/2010
1	Pain (Aches) 09/2010
1	Hypotension (Low Blood Pressure) 03/2010
1	Hypoglycemia (Reactive Hypoglycemia) 08/2009
1	Firesetting Behavior (Arson) 05/2008
1	Hepatocellular Carcinoma (Hepatoma) 01/2007
1	Coumarin Resistance 01/2007
1	Hypoxia (Hypoxemia) 01/2005
1	Synovial Chondromatosis (Synovial Osteochondromatosis) 07/2004
1	Renal Insufficiency (Renal Failure) 06/2004
1	Fibrosis (Cirrhosis) 12/2002
1	Pulmonary Arterial Hypertension 11/2002
1	Heart Failure 09/2002

Drug/Important Bio-Agent (IBA)

3	Anesthetics (Anesthetic Agents)IBA 01/2019 - 01/2016
2	Messenger RNA (mRNA)IBA 01/2016 - 01/2005
2	Vitamin E FDA LinkGeneric 03/2010 - 01/2007
1	dienogest FDA Link 12/2019
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 12/2019
1	GonadotropinsIBA 04/2018
1	graphene oxideIBA 09/2016
1	Ethanol (Ethyl Alcohol)IBA 09/2016
1	Oxidoreductases (Dehydrogenase)IBA 01/2016
1	1-(carboxymethylthio)tetradecaneIBA 01/2016
1	Cortisone FDA Link 01/2016
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2016
1	General AnestheticsIBA 01/2016
1	Biological ProductsIBA 09/2014
1	Keratins (Keratin)IBA 09/2014
1	Warfarin (Coumadin)FDA LinkGeneric 12/2010
1	NiceritrolIBA 12/2010
1	Pravastatin (Pravachol)FDA LinkGeneric 12/2010
1	Enalapril FDA LinkGeneric 12/2010
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2010
1	ZincIBA 09/2010
1	CopperIBA 09/2010
1	Folic Acid (Vitamin M)FDA LinkGeneric 09/2010
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 09/2010
1	polysulfone P 1700 (UDEL)IBA 03/2010
1	MacrolidesIBA 12/2009
1	Insulin (Novolin)FDA Link 08/2009
1	AntibodiesIBA 08/2009
1	SulfurIBA 05/2008
1	Vitamin K 2 (Vitamin K2)IBA 01/2007
1	VitaminsIBA 01/2007
1	QuinolonesIBA 01/2007
1	Amino Acids FDA Link 01/2007
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2007
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2005
1	Interleukin-1 (Interleukin 1)IBA 01/2005
1	Matrix Metalloproteinases (MMPs)IBA 01/2005
1	Metalloproteases (Metalloproteinases)IBA 01/2005
1	Tissue Inhibitor of Metalloproteinase-3IBA 01/2005
1	Eosine Yellowish-(YS) (Eosin)IBA 07/2004
1	Coloring Agents (Dyes)IBA 07/2004
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 07/2004
1	Advanced Glycation End ProductsIBA 06/2004
1	Type 1 Angiotensin ReceptorIBA 12/2002
1	Vasodilator Agents (Vasodilators)IBA 11/2002
1	Angiotensin II Type 1 Receptor BlockersIBA 09/2002

Therapy/Procedure

2	Renal Dialysis (Hemodialysis) 03/2010 - 08/2009
1	Protective Clothing 12/2021
1	Anesthesia 01/2019
1	Intraperitoneal Injections 04/2018
1	Physical Therapy Modalities (Physical Therapy Technique) 01/2013
1	Therapeutics 12/2009